Skip to main content

Celldex Therapeutics, Inc.

CLDXNASDAQ
$31.65-0.53 (-1.65%)as of Oct 2, 2026
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Celldex Therapeutics, Inc. price and activity chart data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+22.4%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
Wellington Management Group LLP12.16%$355M0.06%Add 11.49%
BlackRock, Inc.8.92%$261M0.00%Not reported
Kynam Capital Management, LP6.78%$198M10.95%Reduce 8.86%
State Street Corp4.97%$145M0.00%Not reported
FMR LLC4.74%$139M0.01%Not reported
Vanguard Capital Management LLC4.41%$129M0.00%Not reported
Deep Track Capital, LP3.74%$109M1.59%Add 128.91%
Logos Global Management LP2.68%$78.1M3.36%Add 366.67%
Geode Capital Management, LLC2.58%$75.3M0.00%Not reported
Eversept Partners, LP2.28%$66.5M3.45%Reduce 0.12%
Goldman Sachs Group Inc2.06%$60.1M0.01%Not reported
Assenagon Asset Management S.A.2.01%$58.7M0.04%Not reported
Commodore Capital LP1.72%$50.2M2.99%Reduce 49.94%
Bellevue Group AG1.53%$44.7M0.94%Not reported
Baker Bros. Advisors LP1.51%$44M0.22%Add 77.74%
Millennium Management LLC1.49%$43.6M0.02%Not reported
Dimensional Fund Advisors LP1.37%$40M0.01%Not reported
American Century Companies Inc1.33%$38.8M0.02%Not reported
Eventide Asset Management, LLC1.32%$38.6M0.52%Not reported
Novo Holdings A/S1.31%$38.1M2.21%Reduce 14.58%
Elmind Capital, LP1.26%$36.8M9.25%Add 14.45%
Driehaus Capital Management LLC1.26%$36.8M0.21%New Not reported
Fisher Asset Management, LLC1.26%$36.7M0.01%Reduce 2.76%
Pictet Asset Management Holding SA1.17%$34.1M0.03%Reduce 0.68%
Foresite Capital Management VI LLC1.12%$32.7M5.09%Add 178.47%
Vanguard Portfolio Management LLC1.10%$32.1M0.00%Not reported
Northern Trust Corp0.92%$26.8M0.00%Not reported
Woodline Partners LP0.89%$26.1M0.08%Not reported
Affinity Asset Advisors, LLC0.89%$26M1.18%Add 40.00%
Rock Springs Capital Management LP0.89%$26M1.27%Add 7.52%
Two Sigma Investments, LP0.84%$24.6M0.02%Not reported
Charles Schwab Investment Management Inc0.84%$24.4M0.00%Not reported
Algert Global LLC0.83%$24.1M0.29%Not reported
ADAR1 Capital Management, LLC0.79%$23.1M1.06%Add 44.82%
Bank of America Corp0.77%$22.6M0.00%Not reported
Panagora Asset Management Inc0.73%$21.3M0.07%Not reported
Nuveen, LLC0.72%$21.2M0.01%Not reported
Vanguard Fiduciary Trust Co0.70%$20.6M0.00%Not reported
5AM Venture Management, LLC0.63%$18.5M6.43%Not reported
Federated Hermes, Inc.0.63%$18.3M0.03%Not reported
UBS Group AG0.61%$17.9M0.00%Not reported
Ikarian Capital, LLC0.61%$17.8M1.92%Add 3.74%
Braidwell LP0.56%$16.2M0.60%Reduce 67.80%
Redmile Group, LLC0.55%$16.1M1.08%Not reported
Citigroup Inc0.52%$15.1M0.01%Not reported
Palo Alto Investors LP0.51%$14.9M2.06%Add 34.90%
TSP Capital Management Group, LLC0.47%$13.8M3.30%New Not reported
PFM Health Sciences, LP0.44%$12.8M1.09%Add 5.48%
Kennedy Capital Management LLC0.44%$12.7M0.23%Reduce 2.83%
Segall Bryant & Hamill, LLC0.43%$12.5M0.15%Reduce 3.06%
50 of 239 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.